Known therapeutic targets for breast cancer are uncovered under the Type 1 genes, such as estrogen receptor (ER, or ESR) and human epidermal growth factor receptor 2 (ERBB2, or HER2/neu), which are identified as gene switches for this cancer, and their bimodality in the cancer samples represent well-known subtypes in breast cancer. This evidence concerns the gene ERBB2 and breast cancer.